Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Long-term risk of tuberculosis among migrants according to migrant status: a cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cohort profile: Effective Perinatal Intensive Care in Europe (EPICE) very preterm birth cohort

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Cohort Profile: The Copenhagen Child Cohort Study (CCC2000)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Gynaecological cancer leads to long-term sick leave and permanently reduced working ability years after diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prevalence of human papillomavirus in oral epithelial dysplasia: Systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Suzanne C Dixon
  • Christina M Nagle
  • Aaron P Thrift
  • Paul Dp Pharoah
  • Celeste Leigh Pearce
  • Wei Zheng
  • Jodie N Painter
  • Georgia Chenevix-Trench
  • Peter A Fasching
  • Matthias W Beckmann
  • Diether Lambrechts
  • Ignace Vergote
  • Sandrina Lambrechts
  • Els Van Nieuwenhuysen
  • Mary Anne Rossing
  • Jennifer A Doherty
  • Kristine G Wicklund
  • Jenny Chang-Claude
  • Anja Rudolph
  • Kirsten B Moysich
  • Kunle Odunsi
  • Marc T Goodman
  • Lynne R Wilkens
  • Pamela J Thompson
  • Yurii B Shvetsov
  • Thilo Dörk
  • Tjoung-Won Park-Simon
  • Peter Hillemanns
  • Natalia Bogdanova
  • Ralf Butzow
  • Heli Nevanlinna
  • Liisa M Pelttari
  • Arto Leminen
  • Francesmary Modugno
  • Roberta B Ness
  • Robert P Edwards
  • Joseph L Kelley
  • Florian Heitz
  • Beth Y Karlan
  • Susanne K Kjær
  • Estrid Vilma Solyom Høgdall
  • Allan Jensen
  • Ellen L Goode
  • Brooke L Fridley
  • Julie M Cunningham
  • Stacey J Winham
  • Graham G Giles
  • Fiona Bruinsma
  • Claus K Høgdall
  • Lene Lundvall
  • AOCS Group & Australian Cancer Study (Ovarian Cancer)
Vis graf over relationer

BACKGROUND: Observational studies have reported a positive association between body mass index (BMI) and ovarian cancer risk. However, questions remain as to whether this represents a causal effect, or holds for all histological subtypes. The lack of association observed for serous cancers may, for instance, be due to disease-associated weight loss. Mendelian randomization (MR) uses genetic markers as proxies for risk factors to overcome limitations of observational studies. We used MR to elucidate the relationship between BMI and ovarian cancer, hypothesizing that genetically predicted BMI would be associated with increased risk of non-high grade serous ovarian cancers (non-HGSC) but not HGSC.

METHODS: We pooled data from 39 studies (14 047 cases, 23 003 controls) in the Ovarian Cancer Association Consortium. We constructed a weighted genetic risk score (GRS, partial F-statistic = 172), summing alleles at 87 single nucleotide polymorphisms previously associated with BMI, weighting by their published strength of association with BMI. Applying two-stage predictor-substitution MR, we used logistic regression to estimate study-specific odds ratios (OR) and 95% confidence intervals (CI) for the association between genetically predicted BMI and risk, and pooled these using random-effects meta-analysis.

RESULTS: Higher genetically predicted BMI was associated with increased risk of non-HGSC (pooled OR = 1.29, 95% CI 1.03-1.61 per 5 units BMI) but not HGSC (pooled OR = 1.06, 95% CI 0.88-1.27). Secondary analyses stratified by behaviour/subtype suggested that, consistent with observational data, the association was strongest for low-grade/borderline serous cancers (OR = 1.93, 95% CI 1.33-2.81).

CONCLUSIONS: Our data suggest that higher BMI increases risk of non-HGSC, but not the more common and aggressive HGSC subtype, confirming the observational evidence.

OriginalsprogEngelsk
TidsskriftInternational Journal of Epidemiology
Vol/bind45
Udgave nummer3
Sider (fra-til)884-95
Antal sider12
ISSN0300-5771
DOI
StatusUdgivet - jun. 2016

ID: 49500954